India: Bharat Biotech's COVID-19 nasal vaccine approved for restricted use in India

Bharat Biotech's COVID-19 nasal vaccine approved for restricted use in India Bharat Biotech's COVID-19 recombinant nasal vaccine has been approved by the Indian drug regulator, the country's health minister Mansukh Mandaviya tweeted on Tuesday. Reuters Reuters

Also see: India gets first COVID-19 nasal vaccine. Why it could reduce infection, stop transmission

... The vaccine, which has been developed by Bharat Biotech with technology in-licensed from Washington University-St Louis, has been approved for primary immunisation, meaning it can be given to the unimmunised to protect against COVID-19.

...